Cancer of the Lung And SeneScencE - Prospective Cohort 1

Recruiting N/A Interventional Study
Non-Small Cell Lung Cancer
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
70 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
385 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main objective is to identify and assess the predictive value of ageing and senescence biomarkers (methylome, telomeres, inflammageing) and senescent cells in tissues to improve prognosis assessment older patients with locally or locally-advanced Non-Small Cell Lung Cancer (NSCLC).

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients 70 years and over * Local or locally advanced (Clinic stage I-IIIA) NSCLC (clinically (or radiologically) suspected or histologically proven) * Surgical Curative Intent * Signed informed Consent (or signed by the curator or tutorship) * Affiliated to social security a…
Contacts

Florence CANOUÏ-POITRINE, PhD

01 49 81 36 74

florence.canoui-poitrine@aphp.fr

CONTACT

Adèle BELLINO, Project advisor

01 71 76 07 57

adele.bellino@aphp.fr

CONTACT